Zydus Lifesciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 2,745.40 | 6,005 | 2,593.40 |
| Operating Expense | 2,002.90 | 2,046.90 | 1,867.40 |
| Net Profit | 384.70 | 2,813.70 | 470.60 |
| Net Profit Margin | 14.01 | 46.86 | 18.15 |
| Earning Per Share | 3.82 | 27.96 | 4.68 |
| EBIDTA | 741.90 | 3,923.60 | 675.20 |
| Effective Tax Rate | 12.07 | 20.88 | -3.33 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 2745.40 |
| Operating Expense | 2002.90 |
| Net Profit | 384.70 |
| Net Profit Margin | 14.01 |
| Earning Per Share | 3.82 |
| EBIDTA | 741.90 |
| Effective Tax Rate | 12.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 15,116.30 | 10,818.70 | 8,731.60 |
| Operating Expenses Annual | 7,380 | 6,760 | 6,277.20 |
| Operating Profit Annual | 8,432.50 | 5,134.90 | 2,799 |
| Interest Annual | 463.90 | 390.70 | 278.20 |
| Depreciation | 523.90 | 504.40 | 488.60 |
| Net Profit Annual | 5,774.90 | 3,441.50 | 1,529.20 |
| Tax Annual | 1,669.80 | 798.30 | 503 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 15,116.30 |
| Operating Expenses Annual | 7,380 |
| Operating Profit Annual | 8,432.50 |
| Interest Annual | 463.90 |
| Depreciation | 523.90 |
| Net Profit Annual | 5,774.90 |
| Tax Annual | 1,669.80 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 108.10 | 240.40 | 294.50 |
| Cash Flow from Operations | 3,114 | 2,000.30 | 1,078.20 |
| Cash Flow from Investing | -4,503.60 | -1,831.80 | -1,959.30 |
| Cash Flow from Financing | 1,384.50 | -300.80 | 827 |
| Cash Flow at the End | 103 | 108.10 | 240.40 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 108.10 |
| Cash Flow from Operations | 3,114 |
| Cash Flow from Investing | -4,503.60 |
| Cash Flow from Financing | 1,384.50 |
| Cash Flow at the End | 103 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 55.78 | 47.46 | 32.06 |
| PBIT Margin (%) | 52.32 | 42.80 | 26.46 |
| PBT Margin (%) | 52.21 | 42.69 | 26.36 |
| Net PROFIT Margin (%) | 38.20 | 31.81 | 17.51 |
| Return On Networth / Equity (%) | 31.29 | 23.45 | 11.38 |
| Return On Networth /Employed (%) | 30.47 | 22.73 | 13.31 |
| Return On Assets (%) | 22.16 | 16.86 | 8.76 |
| Total Debt / Equity (X) | 0.39 | 0.37 | 0.28 |
| Asset Turnover Ratio (%) | 0.58 | 0.53 | 0.50 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 55.78 |
| PBIT Margin (%) | 52.32 |
| PBT Margin (%) | 52.21 |
| Net PROFIT Margin (%) | 38.20 |
| Return On Networth / Equity (%) | 31.29 |
| Return On Networth /Employed (%) | 30.47 |
| Return On Assets (%) | 22.16 |
| Total Debt / Equity (X) | 0.39 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 4,202.10 | 4,376.60 | 4,184.10 |
| Total Current Assets Annual | 15,314.70 | 7,911.30 | 7,158.20 |
| Non Current Assets Annual | 17,002.20 | 16,149 | 13,405.40 |
| Total Shareholders Funds Annual | 21,190.10 | 15,716.50 | 13,639.40 |
| Total Assets Annual | 32,316.90 | 24,084.80 | 20,563.60 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 4,202.10 |
| Total Current Assets Annual | 15,314.70 |
| Non Current Assets Annual | 17,002.20 |
| Total Shareholders Funds Annual | 21,190.10 |
| Total Assets Annual | 32,316.90 |
EPS (INR)
Expected
14.58
Reported
14.58
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
